Cencora, Inc.
COR Healthcare Medical Distribution
Cencora, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $321.3 billion, up 9.31% from fiscal 2024. In the quarter to June 2026, revenue grew 5.07%, EPS grew 11.3%, free cash flow grew 3,385.3% and total debt rose 42.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for three consecutive years, revenue growth for ten; insiders bought in the last twelve months.
Follow COR
Cencora, Inc. (COR) Free cash flow
Cencora, Inc.'s free cash flow for fiscal 2025 was $3.2B, up 6.99% from $3.0B in fiscal 2024. Over the twelve months to 30 June 2026 it was $4.1B. Over the past ten years it has ranged from $1.0B (fiscal 2017) to $3.7B (fiscal 2015); the current reading is higher than 82% of that period. Cencora, Inc. ranks 3rd of 11 Medical Distribution companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $3.2B | 6.99% |
| FY2024 | $3.0B | (13.19%) |
| FY2023 | $3.5B | 56.47% |
| FY2022 | $2.2B | (0.97%) |
| FY2021 | $2.2B | 18.93% |
| FY2020 | $1.9B | (7.93%) |
| FY2019 | $2.0B | 87.90% |
| FY2018 | $1.1B | 4.37% |
| FY2017 | $1.0B | (61.76%) |
| FY2016 | $2.7B | (26.47%) |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Jun 2026 | $2.4B | 107.04% |
| Mar 2026 | $1.2B | — |
| Dec 2025 | −$2.4B | — |
| Sep 2025 | $2.9B | — |
| 42 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| MCK McKesson Corporation compare | $6.1B |
| CAH Cardinal Health, Inc. compare | $4.6B |
| COR Cencora, Inc. | $4.1B |
| HSIC Henry Schein, Inc. compare | $569.0M |
| HKPD Cellyan Biotechnology Co., Ltd compare | $144.2K |
| COSM Cosmos Health Inc. compare | −$12.5M |
| FOCL FocalTherics compare | −$19.1M |
| AHG Akso Health Group Sponsored ADR compare | −$160.2M |
| ACH Accendra Health, Inc. compare | −$210.9M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on COR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement